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The airborne dispersion of particles from 55 people (30 females and 25 males) was measured. The
dispersion per minute of microbe carrying particles (MCPs) averaged 2,400 when wearing personal
indoor clothing, and 177 when wearing cleanroom garments. One exceptional person, whose
dispersal rates were not included in these results, dispersed 11,000 per minute when wearing
cleanroom garments. The dispersion rate of particles ≥5µm per minute averaged 332,000 when
wearing indoor clothing, and 37,300 when wearing cleanroom garments. The dispersion rate of
particles ≥0.5µm per minute averaged 2,130,000 when wearing indoor clothing, and 1,020,000 when
wearing cleanroom garments. The dispersion rates for particles and MCPs were higher in males than
females. Depending on the method used, the average equivalent particle diameter of the MCPs was
9µm or 18µm.
There was no situation where the dispersion of MCPs was not accompanied by substantial
numbers of both ≥0.5µm and ≥5.0µm airborne particles, and there appears to be little advantage in
measuring particles ≥5.0µm when using airborne particle counting to indirectly monitor the
dispersion of MCPs. When wearing cleanroom garments, the ratio of ≥0.5µm particles to MCPs was
found to average 5,800:1, and for ≥5.0µm particles it was 210:1.
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Introduction
Microbes in cleanroom air are almost exclusively derived from
personnel within the room. People shed one outermost layer of
epithelial cells every 24 hours, this amounting to about 109
cells per day1. Skin cells are approximately 33µm x 44µm in
surface area and about 3 to 5µm thick, and may be found in the
environment either as whole cells or fragments, the median
size across the surface being about 20µm, with 7-10% less
than 10µm1. Micro-organisms grow on the cells and glands of
the skin and are dispersed into the air on skin detritus. These
particles are therefore often called microbe carrying particles
(MCPs). MCPs will vary in size, shape, and density, and it is
conventional to consider the size of particles in terms of
equivalent particle diameter, which is the size of a sphere of
unit density that has the same aerodynamic properties as the
particle being considered. It therefore follows that a skin cell,
which has a surface diameter of about 20µm but a thickness of
3 to 5µm is likely to have an equivalent particle diameter
below 20µ. Noble, Lidwell and Kingston2, and Whyte3, have
investigated the equivalent particle diameter of MCPs
dispersed from people, and Whyte, Green and Albisu4 have
compiled these results and reported that the average size is
about 12µm, with 1% below 1µm, 25% below 7µm, 25%
above 24µm, and 5% above 50µm. This size distribution
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shows that if non viable particles ≥0.5µm were sampled by use
of a particle counter then 100% of MCPs would be counted
and, if particles ≥5.0µm were sampled, it can be calculated
using the method given in Whyte, Green and Albisu’s paper
that about 83% of the MCPs would be counted.
MCPs and inert particles are kept at a low concentration in
cleanroom air. This is done by supplying HEPA filtered air
and by minimising the dispersion from people by use of
occlusive clothing. From a knowledge of the dispersion rate
of MCPs and particles, as well as the air supply to a room, the
likely airborne concentration in a cleanroom can be
calculated, this method being described by Whyte5, and
Ljungqvist and Reinmüller6.
The reduction of the dispersion of MCPs by cleanroom
garments has been reported by Whyte and Bailey7, who have
also reported on the reduction of the dispersion of particles8.
Reinmüller and Ljungqvist9 have also published information
on this topic. However, these and similar dispersion studies
have been carried out on one person, or on small groups of
people. Additional information is required to establish the
rates of dispersal of MCPs and total particles by the normal
population, and on the ratio of total particles to MCPs, and
differences in dispersion rates between males and females.
Annex 1 (2003) of the European Commission Guide to
Good Manufacturing Practice (EC GGMP)10 gives information
on concentrations of airborne particles and microbes that
should not be exceeded in cleanrooms where sterile
pharmaceutical products are manufactured. Airborne MCPs
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must be controlled in cleanrooms, or they may deposit into
pharmaceutical products. However, the requirement for
controlling inert airborne particles is less clear. Although
an occasional inert particle will deposit from the air into
containers, the particle deposition into containers has been
studied in several pharmaceutical manufacturing
cleanrooms, and shown to be insignificant with respect to
the regulatory limits set11, 12, and unlikely to harm patients
who receive the product13. Particles found in containers
after manufacture do not come from air but from
containers and stoppers11. It is even less clear why airborne
particles ≥5µm should be measured in pharmaceutical
cleanrooms, especially as their concentration is so low as
to be below accurate and reliable measurement. The FDA
Guidance (2004)14 does not have such a requirement.
Informal discussions with the European Medicines Agency
have suggested that they consider that because particles
≥5µm are closer in size to MCPs than ≥0.5µm particles,
they need to be monitored. It has also been suggested that
particles ≥5µm can be found with no accompanying
particles ≥0.5µm, and therefore need to be independently
counted. These suggestions require investigation.
Measurement of particle and microbial
dispersion from people
The measurement of airborne particles and microbe
carrying particles was carried out in a dispersal chamber.
This is the same design as was used in a series of studies
starting in 197615. It has the advantage over previous
designs as the airborne dispersion rate, i.e. number per
minute, can be measured.
Description of dispersal chamber
The dispersal chamber where a person exercised is shown
in Figure 1. It was 0.68m x 0.52m x 2m high and was made
of metal frame covered with clear plastic sheet. Air was
supplied at the top of the chamber and passed through a
HEPA filter (a) into the chamber. Air was normally
supplied at just over 700L/min, and balanced by the
removal of air by a high-volume bacterial sampler (Casella
slit sampler) operating at 700L/min, and an airborne
particle counter operating at 2.83L/min, at sampling port
(c). A slight positive pressure was maintained inside the
chamber to ensure that no contamination entered the
chamber from outside. This outward flow was checked by
an anemometer at the exhaust ports (d).
Personnel tested and clothing worn
Testing was carried out on 55 people (30 females and 25
males). All of the females worked within a cleanroom of a
pharmaceutical manufacturing company. So did the
majority of men, but to make the numbers more even,
some male technicians from Glasgow University were
tested. Each subject was tested while wearing the
following two types of clothing: 
1 Personal indoor clothing: Trousers were worn by all
subjects except 6 females, who wore skirts. A blouse,
shirt, or T shirt was also worn, and clean plastic
overshoes were worn over shoes.
2 Cleanroom garments, manufactured from woven
polyester fabric, were worn on top of the person’s
indoor clothing. It has been shown that the dispersion
rate is dependant on whether the cleanroom clothing
is new, or washed and sterilised9. The garments were
supplied by the pharmaceutical company and it was
not clear how often they had been worn. It was certain
that none of the garments were new, and the average
use was much greater than 50 times. The polyester
fabric was tested for pore diameter according to the
method laid down in the IEST Recommended
Practice 003.316. This test is a good indicator of the
filtration and occlusive properties of the fabric, which
was shown to have a pore diameter of 25µm. 
A coverall was worn and its trouser bottoms were
covered by knee-length boots. The subject also wore
disposable latex gloves, disposable mask and woven
polyester hood, the hood being tucked into the neck of
the coverall, leaving only the eye area uncovered.
Dispersal chamber test procedure
The test procedure was as follows:
1 The steps leading into the chamber were disinfected.
2 The particle counter, which was used to count
particles ≥0.5µm and ≥5.0µm, was switched on and
the fan speed increased to its maximum to flush the
chamber and reduce the airborne particle count to
practically zero.
Figure 1. Dispersal chamber.
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3 The subject, wearing the required clothing entered the
chamber. The door was then closed. The floor of the
chamber was covered with a foam mat (e) dipped in
disinfectant and wrung out. This ensured that a minimal
amount of particle and microbial contamination was re-
dispersed from the floor during exercise.
4 The subject stood at rest until the total particle count
reduced to practically zero, and became steady.
5 The air supply was then reduced to just over
700L/min.
6 The subject started marching to the beat of a
metronome (1 beat/s), while swinging one arm, and
then the other, up to their shoulder. The metronome
was visible to the person, its position (b) being shown
in Figure 1.
7 After the first minute of the exercise, the bacterial air
sampler, which had a sampling rate of 700L/min, was
switched on and off for between 30s and 4 min,
depending on the likely dispersion rate. Males
wearing their personal indoor clothing were tested for
30s, and when wearing cleanroom clothing they were
tested for 2 minutes. Females wearing their personal
indoor clothing were tested for 1 minute, and for 4
minutes when wearing cleanroom clothing.
8 MCPs were deposited onto plates containing tryptone
soya agar (Oxoid Ltd) supplemented with 0.5%
polysorbate 80 to aid the growth of lypophylic skin
bacteria. The plates were incubated aerobically for 48
hrs at 37°C before counting the bacterial colonies. To
minimise errors, plates were incubated before use and
checked for sterility.
9 The particle counter simultaneously recorded the
concentrations of the total particles greater, or equal
to, 0.5µm and 5.0µm during the exercise.
10 After exercising, the person left the chamber, and the
air supply was increased to a maximum to flush the
chamber.
Calculation of the dispersion rate
The chamber was designed to give a downflow of
unidirectional air. This ensured that during exercise the
concentration of airborne contamination came quickly up
to a maximum plateau concentration. Tests were carried
out that established the airborne contamination took one
minute to reach a maximum. This was used as the time
when microbial and particle sampling began. Assuming
the concentration of airborne dispersion reached a steady
state i.e. the dispersion of particles is balanced by their
removal, the dispersion of airborne contamination per
minute can be calculated by use of the following equation:
D = C x Q/S
Where,
D = Total number of MCPs, or particles, dispersed per
minute
C = Total number of airborne contaminants measured by
the microbial sampler, or particle counter, per minute
Q = air supply rate to chamber (700L/min)
S = sampling rate of microbial sampler (700L/min), or
particle counter (2.8L/min)
In the case of the MCPs, the volume of the air supplied
to, and removed from, the chamber by the slit sampler can
be assumed to be the same, and hence the equation
simplifies to the following:
D = C
In the case of the particle sampler, the sampling rate was
2.83L/min, and the particle dispersion per minute cal-
culated as follows:
D = C x 700/2.8
Sampling efficiency of the microbial
sampling method
As can be seen in Figure 1, the airborne sampler was
connected at the bottom of the chamber by a 10cm
diameter duct. Because of the height of the sampler’s
intake and the distance of the chamber from the floor, the
duct had to turn through 90° in a short distance. The duct’s
sharp turn was likely to cause losses due to impaction of
the MCPs. Some preliminary tests were carried out to
ascertain these losses, and they were thought to be about
25% of the total. It was also known that some microbial
samplers have low collection efficiency17, and therefore
some collection losses were likely when using the Casella
slit sampler. When tested in comparison to other samplers,
the Andersen sampler is normally found to be the most
efficient sampler available17, especially when its entrance
cone is removed18 and it has been suggested as the sampler
by which the efficiency of other samplers should be
assessed19, 20. However, the Casella sampler was chosen in
preference to the Anderson sampler because of its much
higher air sampling rate, which enabled low dispersion
rates to be measured.
To ascertain the combined losses from the intake duct
and the air sampler, a series of experiments using 20
people (11 females and 9 males) compared the counts
from two Anderson samplers (without their entrance
cones) placed on the floor of the dispersal chamber, with
the attached Casella slit sampler. Indoor clothing was
worn and the average count obtained from the slit sampler
was 524/min, and 1366/min from the Andersen sampler.
This gives a ratio between the two counts of 2.6:1, and this
ratio was used to recalculate the count obtained from the
slit sampler i.e. the counts from the slit sampler were
multiplied by 2.6. 
Results of particle and microbial dispersion in
chamber
All of the results in this section are given to 3 significant
places. The results given in this section do not include the
exceptionally high dispersion rate of MCPs obtained from
one person. This is discussed in the next section of this
paper.
Shown in Figure 2 is the dispersion rate per minute of
MCPs, particles ≥0.5µm, and ≥5µm, obtained from 55
people wearing cleanroom garments. The counts on the
left are from females, and those on the right are males.
42 W WHYTE AND M HEJAB
Shown in Figure 3 is a plot of both the number of
particles ≥0.5µm and ≥5µm dispersed per minute from the
55 people in comparison to the dispersal rate of MCPs
from the same people.
Given in Table 1 are the average and range of the
dispersion of MCPs per minute. These results are also
given for males and females wearing both their normal
indoor clothing and cleanroom garments.
Given in Table 2 are the average and range of counts of
the dispersion per minute of particles ≥0.5µm and ≥5µm.
Figure 2. Dispersion of MCPs and particles from 55 people wearing cleanroom garments. Dispersal rates are arranged to show the rates from 
30 females on the left and 25 males on the right.
Figure 3. Relation of MCPs to ≥0.5µm and ≥5µm particles.
Table 1. Average number and range of the dispersion rate per
minute of MCPs from 55 people (25 males and 30 females)
Indoor clothing Cleanroom 
– MCPs garments – MCPs
All - averages 2,400 177
All –range 94 to 13,800 5 to 855
Females - averages 943 144
Females- range 94 to 6,630 5 to 514
Males - averages 4,160 216
Males -range 109 to 13,800 7.8 to 855
These results are also given for males and females wearing
both indoor and cleanroom garments.
Given in Table 3 is the reduction in airborne dispersion of
MCPs and particles when people wore cleanroom garments
over their indoor clothing.
Given in Table 4 are the ratios of the number of particles
and MCPs dispersed per minute by males compared to
females. The males always gave a higher dispersion of
particles. A two-sample t test was used to compare the counts
obtained from the males and females. The dispersion rates of
MCPs, particles ≥0.5µm, and particles ≥5µm were compared
between males and females when they wore both cleanroom
and indoor personnel clothing. The statistical analysis showed
this difference, in all comparisons, to be highly significant i.e.
P < 0.001.
Given in Table 5 are the ratios of the number of particles
≥0.5µm and ≥5µm dispersed per minute, compared to the
number of MCPs dispersed per minute.
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Microbial dispersion from a prolific disperser
A dispersal chamber test was carried out on one unusual
individual. This was in addition to the 55 people, and only
microbial dispersion was recorded. The individual had been
working for some time in a cleanroom without incident.
However, an unusually high percentage of microbes in the
room quite suddenly appeared and were identified as
Micrococcus luteus. The microbial flora of the skin of this
person had changed so that it had become predominately
Micrococcus luteus, and gave an uncountable concentration
on the contact plate samples taken from his clothing. The
cause of this change was uncertain but he had received
antibiotic treatment which could have changed his skin
flora. He was withdrawn from the cleanroom and tests
carried out in the dispersal chamber.
Tests were carried out on the dispersion of MCPs using
the method described in the previous section. These were
carried out on both the person and another male, who acted
as a control. Both were tested using their indoor clothing i.e.
shirt and trousers, and then with cleanroom garments. The
cleanroom garments consisted of sterile factory trousers and
shirt, with a sterile polyester coverall on top. The coverall,
hood, and full length boots were made of the same fabric and
design as used in the previous set of tests carried out on 55
people. Disposable mask, polyester hood, and sterile
disposable latex gloves were also worn.
Given in Table 6 is the microbial dispersion rate
obtained from the prolific disperser and the control
person, when wearing personal indoor clothing and then
cleanroom garments. The MCPs sampled from the prolific
disperser were almost exclusively one species i.e.
Micrococcus luteus, which was most unusual. Two tests
were carried out for each clothing condition, and these
were averaged. The counts were then normalised by
multiplying them by 2.6 to take account of the efficiency
of the microbial air sampler, as previously determined.
The control person gave microbial dispersion rates
within the range of values found with the tests carried out
on 55 people, but the prolific disperser gave unusually
high ones. Shown in Figure 4 is the microbial dispersion
Table 2. Average number and range of the dispersion rate per minute of ≥0.5µm and ≥5µm particles from 55 people 
(25 males and 30 females).
Indoor clothing Cleanroom garments
particles ≥0.5µm particles ≥5µm particles ≥0.5µm particles ≥5µm
All – averages 2,130,000 332,000 1,020,000 37,300
All – range 142,000–14,500,000 3,810-2,110,000 79,700-11,700,000 1,020-263,000
Females – averages 1,720,000 257,000 432,000 29,000
Females – range 142,000-11,800,000 3,810-2,110,000 79,700-1,640,000 1,020-114,000
Males – averages 2,630,000 422,000 1,720,000 47,300
Males – range 250,000-14,500,000 6,350-1,680,000 222,000-11,700,000 3,050-263,000
Table 3. Number of times reduction in airborne dispersion when
cleanroom garments were worn over personnel indoor clothing
MCPs Particles ≥5.0µm Particles ≥0.5µm
All 13.6 8.9 2.1
Females 6.5 8.9 4
Males 19.3 8.9 1.5
Table 4. Ratios, males: females of the number of particles and
MCPs dispersed per minute.
Indoor clothing Cleanroom garments
MCPs ≥0.5µm ≥5µm MCPs ≥0.5µm ≥5µm
4.4:1 1.5:1 1.6:1 1.5:1 4.0:1 1.4:1
Table 5. Ratios of the number of particles ≥0.5µm and ≥5µm
dispersed per minute compared to the MCPs
Indoor clothing Cleanroom garments
particles particles particles particles
≥0.5µm ≥5µm ≥0.5µm ≥5µm
890:1 140:1 5,800:1 210:1
Table 6. Number of MCPs dispersed per minute from two male
personnel wearing indoor and cleanroom garments.
Person tested Indoor clothing Cleanroom garments
Prolific disperser 16,100 11,000
Control person 1,590 6
Figure 4. Dispersion of MCPs per minute from 55 people and the
additional prolific disperser when wearing indoor and cleanroom
garments.
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rates obtained from the 55 people when wearing either
indoor or cleanroom garments, and arranged in order so
that the lowest counts are on the left and the highest counts
are on the right. Also added to the right hand side of the
graph are the counts obtained from the prolific disperser
(person number 56). The maximum dispersion rate
previously observed from the 55 people studied, when
wearing indoor clothing, was 13,800 per minute, and
when wearing cleanroom garments was 855 per minute.
The prolific disperser shed considerably more than the
previously highest disperser when wearing indoor
clothing, and was 13 times more prolific than the previously
highest dispenser when wearing cleanroom garments. 
Particle size of the microbe carrying
particles dispersed
Calculated by an Andersen sampler
An Andersen sampler is a cascade microbial air sampler
that has 6-stages, each stage having 400 holes which
decrease in diameter down through the stages. The
impaction velocity onto each agar surface therefore
increases down through the stages and, as the air passes
down through the stages, the size of particle that is
efficiently deposited onto the agar plate becomes smaller.
This allows the size distribution of the MCPs to be
calculated. The percent cumulated counts, by Andersen
stages, were calculated on a "less than stated size" for each
sampler stage and plotted on log 3-cycle x probability
paper, setting the plot point, in micrometres, as the 50% of
the next stage above. The values for 50% cumulative
particle size impacted on each stage, in terms of
equivalent particle diameter, were obtained from
published results21. These were as follows:
Stage 1 = 9.8µm 
Stage 2 = 6.2µm
Stage 3 = 3.8µm
Stage 4 = 2.2µm
Stage 5 = 0.9µm
The method is more fully explained elsewhere3. From the
line of best fit, the equivalent median diameter is read
from the graph opposite the 50% probability. The result
obtained of the median equivalent particle diameter when
wearing cleanroom garments was 9µm.
Calculated by deposition velocity
The average deposition velocity of MCPs can be
calculated from the following equation.
Deposition velocity (m/s) = Number settling/m
2/s
Number in air/m3
The numbers of MCPs settling/m2/s onto a surface can be
obtained from settle plates and the number/m3 in the
cleanroom air from an air sampler. To obtain this
information, 6 plates, each of 14cm diameter (154cm2
surface area) were arranged around the person exercising
on the dispersal chamber floor, giving a total surface area
of 0.924m2. These plates were exposed for 120 seconds
and an average count of 220 was obtained from 20 people
who were sampled.
Therefore,
Number settling on plates/m2/s = 220 x 1/0.94 x 1/120 = 1.984
At the same time as the plates were exposed, an Andersen
sampler (without entrance cone) was placed on the floor
of the chamber and used to measure the MCPs in the air.
This gave an average count of 1.951/m3.
Therefore,
Deposition velocity (m/s) = 1.984 ÷ 1.951 = 1.02 cm/s
Because of their comparatively large size, MCPs deposit
onto surfaces under the influence of gravity3. Based on
Stokes Law, the following equation can be derived22 that
relates the settling velocity of airborne particles in air to
the equivalent particle diameter:
Settling Velocity =
ρd2g
18η
where,
ρ = density of particle
d = equivalent diameter of particle.
g = acceleration due to gravity
η = viscosity of air
This equation applies to spherical objects. As has been
explained in the introduction of this paper, MCPs are not
spherical, but it is conventional to consider airborne
particles in terms of equivalent particle diameter, which is
the size of a sphere of unit density that has the same
aerodynamic properties as the particle being considered.
Using this approach the density of a particle in the above
equation can be taken as unity (1g/cm3). The viscosity of
air at 20ºC is 1.84 x 10-5kg/m.s, and if the particle
diameter units is expressed in µm, then:
Settling velocity (cm/s) = 0.0032 d2
or, d =     √ settling velocity (cm/s)0.0032
In our example:
Equivalent diameter of MCPs =√ 1.02 = 18µm0.0032
Discussion and conclusions
The dispersion rate of MCPs, particles ≥0.5µm, and ≥5.0µm
from 55 people was measured. Thirty females and 25 males
were studied, this being the largest study that the authors are
aware of. The dispersion rates given in this paper can
therefore be used with more confidence when such
information is required, for example, to calculate the expected
airborne contamination concentration in cleanrooms.
PARTICLE AND MICROBIAL AIRBORNE DISPERSION FROM PEOPLE 45
Large variations in airborne dispersion from people
were apparent, and the rates of dispersion of MCPs,
particles ≥0.5µm, and ≥5.0µm were interlinked i.e. high
dispersers of one type of particle would disperse high rates
of particles of the other two types, and vice versa. The
number of MCPs dispersed per minute, when wearing
indoor clothing, and excluding one exceptional individual,
ranged from 94 to 13,800 (average = 2,400), and when
wearing cleanroom garments ranged from 5 to 855
(average=177). One exceptional individual dispersed
16,000 MCPs per minute when wearing indoor clothing,
and 11,000 per minute when wearing cleanroom
garments. The dispersion rate per minute of airborne
particles ≥0.5µm ranged from 142,000 to 14,500,000
(average=2,133,000) when wearing indoor clothing, and
from 79,700 to 11,700,000 (average=1,020,000) when
wearing cleanroom garments. Similarly, the dispersion
rate of airborne particles ≥5.0µm ranged from 3,810 to
2,110,000 (average=332,000) when wearing indoor
clothing, and from 1,020 to 263,000 (average= 37,300)
when wearing cleanroom garments.
The reduction in the dispersion rates, when cleanroom
garments were worn over personal indoor clothing, was
13.6-fold for MCPs, 8.9-fold for particles ≥5.0µm, and
2.1-fold for particles ≥0.5µm. It has been previously
demonstrated7,8 that the reduction in the dispersion of
MCPs and particles by the use of cleanroom garments was
determined by the tightness of the weave of the cloth, and
the design of the garments. The more occlusive the fabric
and garments, the greater the reduction in airborne
dispersion, and more larger particles would be retained
than smaller particles. The effectiveness of the cleanroom
garments studied in this study was therefore as expected.
The relative dispersion from males and females was
studied. It was found that men dispersed greater numbers
of MCPs and particles and this was confirmed by
statistical analysis. It is well established that males
disperse more MCPs than females23, but the authors are
not aware of any study that has established that males also
disperse more inert particles. It has been suggested by
Noble23, 24 that the possible reasons for the higher rates of
dispersion of MCPs by males is because of the higher
concentration of bacteria on their skin, slightly smaller
size of skin cell, different rates of dispersion from
different regions of the body, and a greater area of skin.
However, McIntosh et al1 have suggested that differences
need only be explained by the higher concentration of
bacteria on the skin of males. Not all skin cells are
colonised by bacteria, and an increase in bacterial
concentration results in more skin cells being colonised,
and hence a greater dispersion rate of MCPs. This latter
explanation would fit better with an unpublished study we
carried out, where we failed to show that the size of MCPs
dispersed from males was smaller than females, or that the
weight and size of an individual (which should reflect
their skin area) influenced the dispersion rate. However,
the full explaination for the differences is uncertain.
The equivalent particle size of MCPs was calculated
using two methods. An Anderson sampler gave an
equivalent particle diameter of 9µ, and a deposition
velocity method, which used simultaneous sampling by
settle plates and an Anderson sampler, gave an average
size of 18µm. The Andersen sampler is possibly the most
efficient sampler commercially available, but has losses in
the intake to the sampler, which selectively remove larger
particle sizes18. This loss was minimised by not using the
intake cone, but deposition losses on the intake holes on
the top stage will reduce the average particle diameter.
There is also some doubt as to whether the d50 sizes used
to calculate the average equivalent diameter are accurate,
especially the values used for the top stages18. When using
the settling velocity method, reliance can be placed on the
settle plate correctly measuring the settling rate, but the
Andersen sampler may underestimate the concentration of
MCPs in the air. The correct average equivalent diameter
is therefore likely to be between the values produced by
the two methods, and the previously suggested size of
12µm4 still appears a reasonable value.
The ratios of the number of particles dispersed of
≥0.5µm and ≥5.0µm diameter, to the number of MCPs,
when wearing cleanroom garments was 5,800 and 210,
respectively. These ratios are similar to those reported by
Reinmüller and Ljungqvist9, who found that the ≥0.5µm
particles to MCPs ratios were between 1,500:1 and
8,000:1, and for the ≥5.0µm particles to MCPs were
between 24:1 and 140:1. These ratios will vary depending
on the volunteers, the design of the clothing, the type of
clothing fabric, and whether the fabric was new,
unwashed and unsterilised. Changes in the ratios may also
occur owing to differences in the sampling efficiency of
microbial air samplers, and different losses in the intake
methods of the particle counters and microbial samplers.
The ratios are also likely to be greater in cleanrooms if
there are additional particle dispersing mechanisms other
than from people e.g. from machinery. 
In Annex 1 (2003) of the EC GGMP10, upper limits of
MCPs and particle concentrations are given for
pharmaceutical cleanrooms. Grade A areas should not
exceed a concentration of 3,500/m3 for particles ≥0.5µm,
1/m3 for particles ≥5.0µm, and 1/m3 for MCPs. If it may
be assumed that the concentration of MCPs (1/m3) is the
prime value that should not be exceeded in order to obtain
a suitable quality of product, and that monitoring of
particles gives additional indirect monitoring of MCPs,
then the maximum count of 3,500/m3 for particles ≥0.5µm
is reasonably close to that expected from the ratios found
in this paper and by Reinmüller and Ljungqvist9.
However, Annex 1 of the EC GGMP requires a count of 
1 particle ≥5.0µm/m3 when the microbial limit is 1/m3.
This microbial limit is too low to fit in with the ratio, and
that suggested in ISO 14698-1 (29 particles ≥5.0µm/m3) is
closer, although still low. It is also interesting to consider
the ratios of particles ≥5.0µm to particles ≥5.0µm. In this
series, the ratio when wearing cleanroom clothing was
found to be 27:1. Eaton25 found an average ratio of 12:1
and 57:1 when sampling in his Grade A and Grade B
cleanroom areas. In ISO 14644-1 the classification limits
for ≥0.5µm particles are 121 times that of the ≥5.0µm
particles e.g. in a Class 5 room the concentration of
particles ≥0.5µm is 3,520/m3 and that of ≥5.0µm is 29.
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However, in Annex 1 the requirement for a Grade A area
is 3,500/m3 for particles ≥0.5µm, but only 1/m3 for
particles ≥5.0µm; this requirement appears to be out of
step with the normal ratio, and incorrect.
It has been suggested in justification of the requirement
to count particles ≥5.0µm in pharmaceutical rooms that an
occasional ≥5.0µm particle can be found in the air without
the accompaniment of ≥0.5µm particles. It is quite clear
from these present studies that MCPs are not dispersed by
people without the accompaniment of both ≥5.0µm and
≥0.5µm particles, and these are in proportion to the
number of MCPs dispersed. MCPs were never found
without particles, and more particles ≥0.5µm are
associated with microbial dispersion than particles
≥5.0µm. Because of the distribution of the sizes of MCPs
in cleanroom air, 100% would be measured when
counting particles ≥0.5µm, and from the known size
distribution of MCP it can be ascertained that 83% of the
MCPs would be measured when counting particles
≥5.0µm4. It therefore appears that the additional
measurement of particles ≥5.0µm to ensure that MCPs are
counted is unnecessary.
To ensure that a pharmaceutical product is fit for use by
a patient, MCPs must be measured and controlled, as the
deposition of airborne microbes is a major source of
product contamination26. However, the case for measuring
and controlling particle concentration is less convincing.
It has been demonstrated that very large changes in the
airborne particle count had no measurable effect on the
particle quality of the product, but that particle
contamination came from the container and closures12, 13.
Similar conclusions were drawn from a series of
experiments carried out by Dutch workers27-29. Particles
must occasionally fall into the product but, in comparison
to the levels of particles permitted in parenterals, it is
insignificant11, 12, and unlikely to be a problem to patients
who are subsequently administered the product13.
However, although the measurement of airborne particles
is unnecessary to ensure the correct product quality, the
measurement of particles is necessary to check that the
cleanroom is functioning correctly. In this situation there
is no benefit in measuring particles ≥5.0µm, and because
of the low concentration, and hence the reliability of the
count obtained, as well as the long sampling time required
because of the low concentration, it is a count to be
avoided. 
Particles ≥5.0µm are found in very low concentrations
in pharmaceutical cleanrooms. To reliably measure them,
very large sample volumes and sampling times must be
used, and spurious results have a disproportionate effect.
Eaton25 has demonstrated this, and other practical
difficulties associated with sampling this size of particle.
It may be concluded that the measurement of particles
≥5.0µm in pharmaceutical cleanrooms is inaccurate and
unnecessary. As the FDA do not require the measurement
of particles ≥5.0µm, the findings in this paper, if accepted
by the European Medicines Agency would assist in the
harmonization of the regulatory standards of the USA and
the EU.
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